Proteasomes reactivator reg gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis

Cellular and Molecular Biology

Volumn 55, Issue SUPP.1, 2009, Pages 1121-1131

  Tian, T ^a   Xiaoyi, W ^a   Xiaotao, L ^b   Guosheng, R ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Proliferation; Proteasomes reactivator; REG gamma

Indexed keywords

CASPASE 3; CD16 ANTIGEN; CYCLINE; ENZYME ACTIVATOR; MESSENGER RNA; PROTEASOME REACTIVATOR REG GAMMA; PROTEIN P21; UNCLASSIFIED DRUG; AUTOANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FC RECEPTOR; KI ANTIGEN; PROTEASOME;

ABSORPTION SPECTROPHOTOMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MDA MB 231 CELL LINE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; RECOMBINANT PLASMID; TUMOR GROWTH; TUMOR MODEL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; AUTOANTIGENS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 74049135287     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/128     Document Type: Article

References (25)

1. Barton L.F., Runnels H.A., Schell T.D., Cho Y., Gibbons R., Tevethia S.S., Deepe G.S. Jr and Monaco J.J., Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol. 2004, 172: 3948-3954.
2. Bianchi S., Paglierani M., Zampi G., Cardona G., Cataliotti L., Bonardi R., Zappa M. and Ciatto S., Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Cancer. 1993, 72: 120-125.
3. Blagosklonny M.V. and Pardee A.B., The restriction point of the cell cycle. Cell Cycle. 2002, 1: 103-110.
4. Brittenden J., Heys S.D., Ross J. and Eremin O., Natural killer cells and cancer. Cancer. 1996, 77: 1226-1243.
5. Cascio P. and Goldberg A.L., Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol. 2005, 398: 336-352.
6. Chen X., Barton L.F., Chi Y., Clurman B.E. and Roberts J.M., Ubiquitin-Independent Degradation of Cell-Cycle Inhibitors by the REG gamma Proteasome. Mol Cell.2007, 26: 843-852.
7. Gao X., Li J., Pratt G., Wilk S. and Rechsteiner M., Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma). Arch Biochem Biophys. 2004, 425: 158-164.
8. Goldberg A.L., Protein degradation and protection against misfolded or damaged proteins. Nature. 2003, 6968: 895-899.
9. LI J., GAO X., Ortega J., Nazif T., Joss L., Bogyo M., Steven A.C. and Rechsteiner M., Lysine 188 substitutions convert the pattern of proteasome activation by REG gamma to that of REGs alpha and beta. EMBO J. 2001, 20: 3359-3369.
10. Lipford J.R. and Deshaies R.J., Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat Cell Biol. 2003, 5: 845-850.
11. LI X., Amazit L., Long W., Lonard D.M., Monaco J.J. and O'Malley B.W., Ubiquitin-and ATP-Independent Proteolytic Turnover of p21 by the REGg-Proteasome Pathway. Molecular Cell. 2007, 26: 831-842.
12. Lee C.J., Kim H.T., Song K.W., Kim S.S., Park H.H. and Yoon Y.D., Ovarian expression of p53 and p21 apoptosis regulators in gamma-irradiated mice. Mol Reprod Dev. 2008, 75: 383-391.
13. Masson P., Andersson O., Petersen U.M. and Young P., Identification and characterization of a Drosophila nuclear proteasome regulator.A homolog of human 11 S REGγ(PA28γ). J Biol Chem. 2001, 276: 1383-1390.
14. Mori Y., Moriishi K. and Matsusra Y., Hepatitis C virus core protein: its coordinate roles with PA28 gamma in metabolic abnormality and carcinogenicity in the liver. Int J Biochem Cell Biol. 2008, 40: 1437-1442.
15. Malumbres M. and Barbacid M., To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001, 1: 222-231.
16. Murata S., Kawahara H., Tohma S., Yamamoto K., Kasahara M., Nabeshima Y., Tanaka K. and Chiba T., Growth retardation in mice lacking the proteasome activator PA28gamma. J Biol Chem. 1999, 274: 38211-38215.
17. Masson P., Lundgren J. and Young P., Drosophila Proteasome regulator REG gamma: transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression. J Mol Biol. 2003, 327: 1001-1012.
18. Obradović D., Tirard M., Némethy Z., Hirsch O., Gronemeyer H. and Almeida O.F., Daxx, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors? Mol Pharmacol. 2004, 65: 761-769.
19. Rechsteiner M., Hill C.P., Mobilizing the proteolytic machine:cell biological roles of proteasome activators and inhibitors. Trend. Cel. Biol. 2005, 15: 27-33.
20. Shibatani T., Carlson E.J., Larabee F., McCormack A.L., Früh K. and Skach W.R., Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes. Mol Biol Cell. 2006, 17: 4962-4971.
21. Shunqian J. and Qimin Z., Oncomolecularbiology is the forefront of basic medical research. World Chinese Journal of Digestology. 2002, 10: 678-680.
22. Yi T, Baek JH, Kim HJ, Choi M.H., Seo S.B., Ryoo H.M., Kim G.S. and Woo K.M., Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. Exp Mol Med. 2007, 39: 213-221.
23. Yixin Z., In: Oncology, 1st Edition: People's Medical Publishing House, Beijing, 1999, pp.108-109.
24. Zannini L., Lecis D., Buscemi G., Carlessi L., Gasparini P., Fontanella E., Lisanti S., Barton L. and Delia D., REG gamma proteasome activator is involved in the maintenance of chromosomal stability. Cell Cycle. 2008, 7: 504-512.
25. Zhang Z. and Zhang R., Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 2008, 27: 852-864.